Merck

  • EU to fine Ranbaxy, others for blocking generic drugs June 4, 2013

    Brussels: A European regulator will fine Denmark's Lundbeck, India's Ranbaxy and seven other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said, its first sanction against "pay-for-delay" deals. Following an inquiry launched in 2009, the European Union's anti-trust regulator will impose...
  • Patent row: Delhi HC to hear diabetes drug case May 23, 2013

    New Delhi: The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. Indian pharma company Glenmark recently came out with generic versions of Merck's type-2...
  • MSD India to invest $ 10 mn to reduce maternal mortality May 14, 2013

    New Delhi: Drug firm MSD India on Tuesday said it will invest USD 10 million over next three years in the country as part of its global initiative to help reduce maternal mortality. As part of the initiative - 'MSD for Mothers', the drug firm would partner three non-governmental organisations...
  • Patent row: HC refuses interim relief to Merck April 5, 2013

    New Delhi: The Delhi High Court on Friday refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark Pharmaceuticals manufacturing and marketing anti-diabetes drugs Zita and Zita-Met. Justice Rajiv Sahai Endlaw dismissed the interim...
  • Gardasil wins approval for anal cancer December 23, 2010

    New York: - Merck & Co's Gardasil vaccine won US approval on Wednesday for preventing anal cancer, providing a new weapon against a rare but rising form of the disease. Both the drugmaker and the US Food and Drug Administration announced the approval, which applies to people ages 9 to 26. Gardasil...
  • Indian pharma part of $150 mn global vaccine venture September 19, 2009

    London: Indian generic drug companies will be the "first to be called" to collaborate with a $150 million joint venture between the US pharmaceutical giant Merck and British medical charity Wellcome Trust to develop and produce new vaccines in India. The new company, MSD Wellcome Trust Hilleman Laboratories, will have 60...
  • Ranbaxy gives up bid for German pharma co June 17, 2007

    New Delhi: India's largest drug firm Ranbaxy seems to have pulled out of the race to acquire German pharmaceutical company Merck's generic business on concerns of over-valuation. Ranbaxy, which is the only Indian company to have entered the second round of bidding, decided to opt out after valuations were stretched to...